Lamy Laureline, François Manon, Bezdetnaya Lina, Yakavets Ilya
Research Department, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne, 54519 Vandoeuvre-lès-Nancy, France; Centre de Recherche en Automatique de Nancy, Centre National de la Recherche Scientifique, UMR 7039, Université de Lorraine, Campus Sciences, Boulevard des Aiguillette, 54506 Vandoeuvre-lès-Nancy, France.
Research Department, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne, 54519 Vandoeuvre-lès-Nancy, France.
Eur J Pharm Biopharm. 2023 Mar;184:1-6. doi: 10.1016/j.ejpb.2023.01.010. Epub 2023 Jan 19.
Photodynamic therapy is a multistage treatment, in which cancerous and precancerous cells are destroyed by light activation of a drug (photosensitizer). For a long time, high cellular uptake of the photosensitizer was an important indication of efficient PDT, while the role of photosensitizer penetration was unexplored. Recently, we have demonstrated that nanosponges based on hypercrosslinked β-cyclodextrin polymer (β-CDp) can increase drug penetration at the cost of their cellular uptake in multicellular spheroids, paving the way for studying the impact of penetration on PDT response. In the present work, we used β-CDp nanosponges to deliver temoporfin to the depth of stroma-rich head and neck cancer multicellular spheroids and then assess PDT response. Encapsulation of temoporfin in β-CDp nanosponges resulted in increased penetration and more uniform distribution of temoporfin in spheroids, however, was also associated with a two-fold reduction of cellular uptake compared to the free drug. Nevertheless, we demonstrated that β-CDp nanosponges possess similar PDT efficiency as the free drug in stroma-rich head and neck cancer multicellular spheroids. Overall, this study suggests that β-CDp nanosponges are a strong candidate for in vivo studies as they have fewer "off-target" effects while providing a similar therapeutic response.
光动力疗法是一种多阶段治疗方法,其中癌性和癌前细胞通过药物(光敏剂)的光激活作用被破坏。长期以来,光敏剂的高细胞摄取是有效光动力疗法的一个重要指标,而光敏剂渗透的作用尚未得到探索。最近,我们已经证明,基于超交联β-环糊精聚合物(β-CDp)的纳米海绵可以以牺牲其在多细胞球体中的细胞摄取为代价来增加药物渗透,为研究渗透对光动力疗法反应的影响铺平了道路。在本研究中,我们使用β-CDp纳米海绵将替莫泊芬递送至富含基质的头颈癌多细胞球体的深部,然后评估光动力疗法反应。替莫泊芬包封在β-CDp纳米海绵中导致替莫泊芬在球体中的渗透增加且分布更均匀,然而,与游离药物相比,细胞摄取也减少了两倍。尽管如此,我们证明β-CDp纳米海绵在富含基质的头颈癌多细胞球体中具有与游离药物相似的光动力疗法效率。总体而言,这项研究表明β-CDp纳米海绵是体内研究的有力候选者,因为它们具有较少的“脱靶”效应,同时提供相似的治疗反应。